WebList - michaelharnoy

michaelharnoy's Page

Your lists :



Michael Har-Noy


Dr. Michael Har-Noy reports that a 12 year old Great Dane with bronchoalveolar adenocarcinoma was treated with a chaperone-rich cell lysate (CRCL) vaccine processed from the dog’s tumor. Dr. Michael Har-Noy indicates that the expected survival of the dog was six to 27 days. After treatment, the dog remained cancer-free for 44 weeks, when a relapse occurred. The dog was euthanized at about 50 weeks post-treatment. Dr. Michael Har-Noy concludes that CRCL vaccine is a safe and very effective
Title
Description